Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Etanercept in Chinese Subjects With Active Rheumatoid Arthritis
NCT00443950Phase 3Completed
- Sponsor
- Pfizer
- Start
- Jun 2006
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 3 trial of etanercept in rheumatoid arthritis (RA), sponsored by Pfizer. Started Jun 2006; status: completed.
02
Drugs
etanercept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00443950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00443950.